• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Marillyn Hewson Joins Chevron’s Board of Directors

    12/2/20 4:30:00 PM ET
    $JNJ
    $CVX
    $LMT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Integrated oil Companies
    Energy
    Get the next $JNJ alert in real time by email

    SAN RAMON, Calif.--(BUSINESS WIRE)--Chevron Corporation (NYSE: CVX) announced that Marillyn A. Hewson has been elected to Chevron’s board of directors, effective on January 1, 2021. She will serve on the Audit Committee of the Board.

    Hewson, 66, is executive chairman of Lockheed Martin Corporation. She served as Lockheed Martin’s chairman, president and chief executive officer from January 2014 to June 2020 and held the positions of president and chief executive officer from January 2013 to December 2013.

    “It’s truly an honor to welcome Marillyn to Chevron’s board,” said Chevron Chairman and CEO Michael Wirth. “Marillyn is one of the world’s most accomplished business leaders. She brings valuable global business experience as well as decades of perspective on international commerce and geopolitics to our board, and will make our company better.”

    Hewson joined Lockheed Martin more than 35 years ago as an industrial engineer. During her career she has held leadership positions across the corporation. She currently serves on the board of directors of Johnson & Johnson, the Congressional Medal of Honor Foundation, the Board of Governors of the USO, and as chair of the Catalyst Board of Directors. Hewson has served on several U.S. government advisory bodies, including her current appointment to the American Workforce Policy Advisory Board. She earned her Bachelor of Science degree in business administration and her Master of Arts degree in economics from The University of Alabama and has completed executive development programs at Columbia Business School and Harvard Business School.

    Chevron Corporation is one of the world’s leading integrated energy companies. Through its subsidiaries that conduct business worldwide, the company is involved in virtually every facet of the energy industry. Chevron explores for, produces and transports crude oil and natural gas; refines, markets and distributes transportation fuels and lubricants; manufactures and sells petrochemicals and additives; generates power; and develops and deploys technologies that enhance business value in every aspect of the company’s operations. Chevron is based in San Ramon, Calif. More information about Chevron is available at www.chevron.com.

    Get the next $JNJ alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $JNJ
    $CVX
    $LMT

    CompanyDatePrice TargetRatingAnalyst
    Johnson & Johnson
    $JNJ
    5/13/2025$153.00Outperform → Market Perform
    Leerink Partners
    Chevron Corporation
    $CVX
    5/13/2025$158.00Buy → Hold
    HSBC Securities
    Chevron Corporation
    $CVX
    5/6/2025$130.00Buy → Sell
    DZ Bank
    Chevron Corporation
    $CVX
    5/5/2025$155.00 → $150.00Hold
    TD Cowen
    Chevron Corporation
    $CVX
    4/23/2025$124.00Neutral → Sell
    Redburn Atlantic
    Lockheed Martin Corporation
    $LMT
    4/23/2025$540.00Neutral → Outperform
    Robert W. Baird
    Chevron Corporation
    $CVX
    4/23/2025$171.00 → $152.00Overweight → Equal Weight
    Barclays
    Lockheed Martin Corporation
    $LMT
    4/16/2025$575.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $JNJ
    $CVX
    $LMT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Pinto Daniel E claimed no ownership of stock in the company (SEC Form 3)

      3 - JOHNSON & JOHNSON (0000200406) (Issuer)

      7/8/25 5:31:26 PM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Donovan John

      4 - LOCKHEED MARTIN CORP (0000936468) (Issuer)

      7/2/25 6:58:04 PM ET
      $LMT
      Military/Government/Technical
      Industrials
    • SEC Form 4 filed by Director Burritt David B

      4 - LOCKHEED MARTIN CORP (0000936468) (Issuer)

      7/2/25 6:58:02 PM ET
      $LMT
      Military/Government/Technical
      Industrials

    $JNJ
    $CVX
    $LMT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Advisory: Chevron Corporation's 2Q 2025 Earnings Conference Call and Webcast

      Chevron Corporation (NYSE:CVX), one of the world's leading energy companies, will hold its quarterly earnings conference call on Friday, August 1, 2025, at 11:00 a.m. ET (10:00 a.m. CT). Conference Call Information: Date: Friday, August 1, 2025 Time: 11:00 a.m. ET / 10:00 a.m. CT Dial-in # (Listen-only mode): 888-240-9352 Conference ID #: 7352942 Speakers: Mike Wirth – Chairman of the Board & Chief Executive Officer Mark Nelson – Vice Chairman Eimear Bonner – Vice President & Chief Financial Officer Jake Spiering – Head of Investor Relations To access the live webcast, visit www.chevron.com. The meeting replay will also be available on the company website under the "Investors" secti

      7/9/25 5:30:00 PM ET
      $CVX
      Integrated oil Companies
      Energy
    • Supplemental new drug application submitted to U.S. FDA for CAPLYTA® (lumateperone) with data demonstrating significant schizophrenia relapse prevention compared to placebo

      Submission is based on long-term Phase 3 data demonstrating 63 percent reduction in risk of relapse in adults with schizophrenia compared to placebo CAPLYTA® is FDA approved to treat schizophrenia and is the first and only approved treatment for bipolar I and II depression as an adjunctive and monotherapy With the addition of CAPLYTA® to Johnson & Johnson's robust portfolio of therapies, the Company now offers the broadest range of treatment options for adults with schizophrenia   TITUSVILLE, N.J., July 8, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) announced today the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) based upon lon

      7/8/25 8:00:00 AM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • JLens and ADL Condemn UN Report Targeting Companies for Israel Ties

      TOV ETF Currently Holds All 13 of the U.S. Public Companies Named in Report and Reaffirms Support for Israel-Aligned Investments JLens, a Registered Investment Advisor and sponsor of the JLens 500 Jewish Advocacy U.S. ETF (NYSE:TOV, the "TOV ETF")), along with the Anti-Defamation League (ADL), the world's leading anti-hate organization, strongly condemn the report issued by UN Special Rapporteur Francesca Albanese during the 59th session of the UN Human Rights Council. Titled "From economy of occupation to economy of genocide," the report urges companies to sever ties with Israel, halt operations, and pay reparations. This press release features multimedia. View the full release here: ht

      7/3/25 11:45:00 AM ET
      $ABNB
      $AMZN
      $BKNG
      $BLK
      Diversified Commercial Services
      Finance
      Catalog/Specialty Distribution
      Consumer Discretionary

    $JNJ
    $CVX
    $LMT
    SEC Filings

    See more
    • SEC Form 11-K filed by Chevron Corporation

      11-K - CHEVRON CORP (0000093410) (Filer)

      6/27/25 4:30:40 PM ET
      $CVX
      Integrated oil Companies
      Energy
    • SEC Form 11-K filed by Lockheed Martin Corporation

      11-K - LOCKHEED MARTIN CORP (0000936468) (Filer)

      6/24/25 4:14:58 PM ET
      $LMT
      Military/Government/Technical
      Industrials
    • SEC Form 11-K filed by Lockheed Martin Corporation

      11-K - LOCKHEED MARTIN CORP (0000936468) (Filer)

      6/24/25 4:14:03 PM ET
      $LMT
      Military/Government/Technical
      Industrials

    $JNJ
    $CVX
    $LMT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Johnson & Johnson downgraded by Leerink Partners with a new price target

      Leerink Partners downgraded Johnson & Johnson from Outperform to Market Perform and set a new price target of $153.00

      5/13/25 8:56:13 AM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chevron downgraded by HSBC Securities with a new price target

      HSBC Securities downgraded Chevron from Buy to Hold and set a new price target of $158.00

      5/13/25 8:52:41 AM ET
      $CVX
      Integrated oil Companies
      Energy
    • Chevron downgraded by DZ Bank with a new price target

      DZ Bank downgraded Chevron from Buy to Sell and set a new price target of $130.00

      5/6/25 8:02:15 AM ET
      $CVX
      Integrated oil Companies
      Energy

    $JNJ
    $CVX
    $LMT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Weinberger Mark A bought $147,220 worth of shares (1,000 units at $147.22) (SEC Form 4)

      4 - JOHNSON & JOHNSON (0000200406) (Issuer)

      12/12/24 5:27:36 PM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $JNJ
    $CVX
    $LMT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • July 21, 2023 - FDA Roundup: July 21, 2023

      For Immediate Release: July 21, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA Center for Tobacco Products (CTP) announced that the center will host a virtual listening session on Aug. 22, 2023. During this listening session, CTP is requesting feedback on the development of a new 5-year strategic plan for the center, includin

      7/21/23 4:02:23 PM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • May 5, 2022 - Coronavirus (COVID-19) Update: FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals

      For Immediate Release: May 05, 2022 Today, the U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and to individuals 18 years of age and older who elect to receive the Janssen COVID-19 Vaccine because they would otherwise not

      5/5/22 4:51:11 PM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • August 18, 2021 - Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots

      For Immediate Release: August 18, 2021 Today, public health and medical experts from the U.S. Department of Health and Human Services (HHS) released the following statement on the Administration’s plan for COVID-19 booster shots for the American people. The statement is attributable to Dr. Rochelle Walensky, Director of the Centers for Disease Control and Prevention (CDC); Dr. Janet Woodcock, Acting Commissione

      8/18/21 1:06:11 PM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $JNJ
    $CVX
    $LMT
    Leadership Updates

    Live Leadership Updates

    See more
    • Johnson & Johnson Elects Daniel Pinto, President, JPMorganChase to its Board of Directors

      Johnson & Johnson (NYSE:JNJ) announced today that Daniel Pinto, President, JPMorganChase, has been elected to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250610707025/en/ "We are thrilled to have Daniel join Johnson & Johnson's Board of Directors," said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. "He is an exceptional leader with deep financial expertise and understanding of global capital markets. Daniel's unique perspective and wealth of experience will be a tremendous asset to Johnson & Johnson as we continue to invest in and advance the next generation of healthcare inno

      6/10/25 4:51:00 PM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chevron Updates Stockholders at Annual Meeting

      Chevron Corporation (NYSE:CVX) today provided an overview of the company's business performance and plans at its Annual Meeting of Stockholders. The meeting highlighted the company's strong performance and consistent strategy, with stockholders showing their support by voting in favor of the full slate of Directors and with the company's recommendations on all matters to be voted upon. "Our strong performance in 2024 and through the first quarter reflects strong project execution and cost and capital discipline," said Mike Wirth, Chevron's chairman and chief executive officer. "We appreciate the confidence our stockholders have shown in our governance and performance and look forward to c

      5/28/25 4:00:00 PM ET
      $CVX
      Integrated oil Companies
      Energy
    • ISS and Glass Lewis Join ADL and JLens in Recommending AGAINST Anti-Israel Shareholder Proposals at Intel, General Dynamics and Lockheed Martin

      Reiterates Call for Shareholders to Reject Proposals Motivated by Antisemitic Boycott, Divestment and Sanctions (BDS) Movement ADL (Anti-Defamation League) and its affiliate, Jlens, welcome the decisions of the two leading independent proxy advisory firms, Institutional Shareholder Services ("ISS") and Glass, Lewis & Co. ("Glass Lewis"), to recommend that investors vote AGAINST anti-Israel shareholder proposals at the upcoming annual meetings of Intel Corporation (NASDAQ:INTC), General Dynamics (NYSE:GD) and Lockheed Martin Corporation (NYSE:LMT). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250505942003/en/ ADL and its Regist

      5/5/25 8:00:00 AM ET
      $GD
      $INTC
      $LMT
      Marine Transportation
      Industrials
      Semiconductors
      Technology

    $JNJ
    $CVX
    $LMT
    Financials

    Live finance-specific insights

    See more
    • Advisory: Chevron Corporation's 2Q 2025 Earnings Conference Call and Webcast

      Chevron Corporation (NYSE:CVX), one of the world's leading energy companies, will hold its quarterly earnings conference call on Friday, August 1, 2025, at 11:00 a.m. ET (10:00 a.m. CT). Conference Call Information: Date: Friday, August 1, 2025 Time: 11:00 a.m. ET / 10:00 a.m. CT Dial-in # (Listen-only mode): 888-240-9352 Conference ID #: 7352942 Speakers: Mike Wirth – Chairman of the Board & Chief Executive Officer Mark Nelson – Vice Chairman Eimear Bonner – Vice President & Chief Financial Officer Jake Spiering – Head of Investor Relations To access the live webcast, visit www.chevron.com. The meeting replay will also be available on the company website under the "Investors" secti

      7/9/25 5:30:00 PM ET
      $CVX
      Integrated oil Companies
      Energy
    • Lockheed Martin Announces Second Quarter 2025 Earnings Results Webcast

      BETHESDA, Md., July 1, 2025 /PRNewswire/ -- Lockheed Martin (NYSE:LMT) will webcast live its second quarter 2025 earnings results conference call (listen-only mode) on Tuesday, July 22, 2025, at 11 a.m. ET. James Taiclet, chairman, president and CEO; Evan Scott, chief financial officer; and Maria Ricciardone, vice president, Treasurer and Investor Relations, will discuss second quarter 2025 results, provide updates on key topics and answer questions. Second quarter 2025 results will be published prior to the market opening on July 22. The live webcast will be available at www.

      7/1/25 4:30:00 PM ET
      $LMT
      Military/Government/Technical
      Industrials
    • Lockheed Martin Declares Third Quarter 2025 Dividend

      BETHESDA, Md., June 25, 2025 /PRNewswire/ -- The Lockheed Martin Corporation (NYSE:LMT) board of directors has authorized a third quarter 2025 dividend of $3.30 per share. The dividend is payable on Sept. 26, 2025, to holders of record as of the close of business on Sept. 2, 2025. About Lockheed MartinLockheed Martin is a global defense technology company driving innovation and advancing scientific discovery. Our all-domain mission solutions and 21st Century Security® vision accelerate the delivery of transformative technologies to ensure those we serve always stay ahead of re

      6/25/25 7:43:00 PM ET
      $LMT
      Military/Government/Technical
      Industrials

    $JNJ
    $CVX
    $LMT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Johnson & Johnson

      SC 13G - JOHNSON & JOHNSON (0000200406) (Filed by)

      4/10/24 5:12:55 PM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G/A filed by Johnson & Johnson (Amendment)

      SC 13G/A - JOHNSON & JOHNSON (0000200406) (Subject)

      2/13/24 5:07:58 PM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G/A filed by Chevron Corporation (Amendment)

      SC 13G/A - CHEVRON CORP (0000093410) (Subject)

      2/13/24 4:55:53 PM ET
      $CVX
      Integrated oil Companies
      Energy